We are live on
!
Find out more
DAM
DLD Asset Management Portfolio holdings
AUM
$1.1B
1-Year Est. Return
4.68%
This Fund
S&P 500
This Quarter
Est. Return
+2.02%
1 Year Est. Return
+4.68%
3 Year Est. Return
+8.24%
5 Year Est. Return
+32.95%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
+$174M
(+14%)
Cap. Flow
-$188M
Cap. Flow
% of AUM
-13.57%
Top 10 Holdings %
Top 10 Hldgs %
38.58%
Holding
461
New
206
Increased
38
Reduced
44
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ELME
Elme Communities
ELME
|
+$7.15M |
| 2 |
Unity
U
|
+$5.63M |
| 3 |
MCGA
Yorkville Acquisition Corp
MCGA
|
+$5.38M |
| 4 |
Liberty Broadband Class C
LBRDK
|
+$5.1M |
| 5 |
GTLS
Chart Industries
GTLS
|
+$4.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITOS
iTeos Therapeutics
ITOS
|
+$5.75M |
| 2 |
KDK
Kodiak AI
KDK
|
+$5.45M |
| 3 |
IMSR
Terrestrial Energy
IMSR
|
+$5.2M |
| 4 |
PPTA
Perpetua Resources
PPTA
|
+$4.05M |
| 5 |
Welltower
WELL
|
+$3.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.38% |
| 2 | Technology | 2.23% |
| 3 | Industrials | 1.84% |
| 4 | Real Estate | 1.38% |
| 5 | Healthcare | 0.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MREO
226
CALL
Mereo BioPharma
MREO
$48.9M
| $245K | 0.02% |
119,000
+94,000
| +376% | +$173K |
|
|
CNTA
227
PUT
DELISTED
Centessa Pharmaceuticals
CNTA
| $243K | 0.02% |
+10,000
| New | +$178K |
|
228
CALL
Walmart Inc
WMT
$909B
| $237K | 0.02% |
2,300
-3,100
| -57% | -$309K |
|
|
TECX
229
Tectonic Therapeutic
TECX
$536M
| $235K | 0.02% |
+15,000
| New | +$310K |
|
230
PUT
Qualcomm
QCOM
$164B
| $233K | 0.02% |
1,400
-1,700
| -55% | -$270K |
|
|
SAFE
231
PUT
Safehold
SAFE
$1.17B
| $232K | 0.02% |
+15,000
| New | +$232K |
|
232
CALL
Agios Pharmaceuticals
AGIO
$2.08B
| $229K | 0.02% |
+5,700
| New | +$214K |
|
233
PUT
Mastercard
MA
$498B
| $227K | 0.02% |
400
-500
| -56% | -$287K |
|
|
ATYR
234
CALL
aTyr Pharma
ATYR
$47.4M
| $223K | 0.02% |
+309,800
| New | +$1.4M |
|
235
CALL
JPMorgan Chase
JPM
$916B
| $221K | 0.02% |
700
-3,900
| -85% | -$1.16M |
|
236
Goldman Sachs
GS
$289B
| $219K | 0.02% |
+275
| New | +$204K |
|
237
CALL
Nektar Therapeutics
NKTR
$2.39B
| $216K | 0.02% |
+3,800
| New | +$126K |
|
238
PUT
State Street Financial Select Sector SPDR ETF
XLF
$56.5B
| $215K | 0.02% |
+4,000
| New | +$212K |
|
239
CALL
Xenon Pharmaceuticals
XENE
$6.1B
| $209K | 0.02% |
+5,200
| New | +$183K |
|
240
CALL
Microsoft
MSFT
$2.9T
| $207K | 0.02% |
+400
| New | +$204K |
|
241
CALL
Morgan Stanley
MS
$319B
| $207K | 0.01% |
+1,300
| New | +$192K |
|
242
PUT
Scholar Rock
SRRK
$5.88B
| $205K | 0.01% |
+5,500
| New | +$192K |
|
243
Eli Lilly
LLY
$1.08T
| $202K | 0.01% |
265
-1,851
| -87% | -$1.38M |
|
|
DVAX
244
CALL
DELISTED
Dynavax Technologies
DVAX
| $190K | 0.01% |
+19,100
| New | +$199K |
|
245
Altimmune
ALT
$568M
| $189K | 0.01% |
50,000
+27,400
| +121% | +$106K |
|
|
TVA
246
Texas Ventures Acquisition III Corp
TVA
$315M
| $179K | 0.01% |
+16,667
| New | +$169K |
|
247
CALL
Kenvue
KVUE
$38B
| $169K | 0.01% |
+10,400
| New | +$212K |
|
248
PUT
AtaiBeckley Inc
ATAI
$2.66B
| $168K | 0.01% |
+31,800
| New | +$129K |
|
249
PUT
Replimune Group
REPL
$454M
| $167K | 0.01% |
+40,000
| New | +$256K |
|
250
Dole
DOLE
$1.38B
| $161K | 0.01% |
+12,000
| New | +$168K |
|
Similar funds
PRS
LCM
MAM
PHS
DAM
AC
YL
KCM
DLD Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, DLD Asset Management held 461 positions worth $1.38B, up 14% from $1.21B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
DLD Asset Management withdrew a net $188M in Q3 2025, closing 115 positions and reducing 44 holdings. Its most notable exit was iTeos Therapeutics, an estimated $5.75M position sold in full.
By sector, the portfolio is most concentrated in Financials at 7.4% of assets, up from 5.5% a quarter earlier, followed by Technology and Industrials.
Against the trend, DLD Asset Management opened a new position in Elme Communities worth $7.29M.
- DLD Asset Management's largest Q3 2025 buy was Elme Communities: 432,377 shares worth $7.29M.
- DLD Asset Management added most to Marti Technologies in Q3 2025, an estimated $3.56M increase.
- DLD Asset Management's biggest Q3 2025 reduction was Welltower, cutting an estimated $3.97M.
- DLD Asset Management fully exited iTeos Therapeutics in Q3 2025, selling an estimated $5.75M.
- DLD Asset Management's ten largest holdings make up 39% of its $1.38B portfolio in Q3 2025.
- DLD Asset Management opened 206 new positions and closed 115 in Q3 2025.
- DLD Asset Management's portfolio value rose 14% quarter-over-quarter to $1.38B.
Based on DLD Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.